We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Credit Suisse Group | NYSE:CS | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.8858 | 0 | 01:00:00 |
From May 2019 to May 2024
Bayer AG (BAYRY) is considering selling its diabetes device business, which could fetch the Germany company up to EUR2 billion, Bloomberg News reported Monday on its website, citing people with knowledge of the matter.
Bayer, which has hired Credit Suisse Group AG (CS) to assist with the process, also plans to list its plastics unit on the stock market, Bloomberg reported.
Full story at: www.businessweek.com/news/2014-11-24/bayer-said-to-explore-sale-of-2-dot-5-billion-diabetes-unit
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Credit Suisse Chart |
1 Month Credit Suisse Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
